Target Name: MAP3K10
NCBI ID: G4294
Review Report on MAP3K10 Target / Biomarker Content of Review Report on MAP3K10 Target / Biomarker
MAP3K10
Other Name(s): M3K10_HUMAN | MKN28 kinase | Mitogen-activated protein kinase kinase kinase 10 | MEKK10 | mitogen-activated protein kinase kinase kinase 10 | MST | MKN28 derived nonreceptor_type serine/threonine kinase | protein kinase MST | MLK2 | Protein kinase MST | Mixed lineage kinase 2 | mixed lineage kinase 2

MAP3K10: A Protein Involved in Cell Signaling Pathways

MAP3K10, also known as M3K10, is a protein that is expressed in various tissues of the human body. It is a member of the MAPK10 family, which includes several similar proteins that play a crucial role in cell signaling pathways. One of the most significant functions of MAP3K10 is its role in the regulation of cell proliferation and differentiation.

MAP3K10 is involved in several signaling pathways that are critical for normal development and growth. One of the well-studied functions of MAP3K10 is its role in the regulation of cell proliferation. MAP3K10 has been shown to play a negative role in the growth and proliferation of cancer cells. Studies have shown that inhibiting the activity of MAP3K10 can lead to a reduction in the growth and spread of cancer cells.

Another function of MAP3K10 is its role in the regulation of cell differentiation. MAP3K10 is involved in the regulation of cell adhesion and migration, which are critical processes that are essential for the development of tissues and organs. Studies have shown that MAP3K10 plays a positive role in the regulation of cell adhesion and migration, and that inhibiting its activity can lead to defects in tissue formation and growth.

MAP3K10 is also involved in the regulation of cellular stress responses. Stress can cause significant damage to cells, and MAP3K10 is involved in the regulation of cellular stress responses. Studies have shown that MAP3K10 plays a critical role in the regulation of cellular stress responses, and that inhibiting its activity can lead to defects in cellular stress resilience.

In addition to its role in cell signaling pathways, MAP3K10 is also involved in the regulation of cellular death. Studies have shown that MAP3K10 plays a negative role in the regulation of cellular death, and that inhibiting its activity can lead to increased cell survival. This is important because increased cell survival can lead to the development of cancer.

MAP3K10 is also involved in the regulation of inflammation. Studies have shown that MAP3K10 plays a critical role in the regulation of inflammatory responses, and that inhibiting its activity can reduce inflammation. This is important because chronic inflammation can lead to a host of diseases, including cancer.

In conclusion, MAP3K10 is a protein that is involved in several critical signaling pathways that are essential for normal cellular function. Its activity is regulated by multiple factors, including its own activity, and the activity of other proteins. In addition to its role in cell signaling pathways, MAP3K10 is also involved in the regulation of cell differentiation, stress responses, and inflammation. Given its critical role in cellular function, MAP3K10 is a potential drug target and a biomarker for a variety of diseases.

Protein Name: Mitogen-activated Protein Kinase Kinase Kinase 10

Functions: Activates the JUN N-terminal pathway

The "MAP3K10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MAP3K10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MAP3K11 | MAP3K12 | MAP3K13 | MAP3K14 | MAP3K14-AS1 | MAP3K15 | MAP3K19 | MAP3K2 | MAP3K2-DT | MAP3K20 | MAP3K20-AS1 | MAP3K21 | MAP3K3 | MAP3K4 | MAP3K5 | MAP3K5-AS2 | MAP3K6 | MAP3K7 | MAP3K7CL | MAP3K8 | MAP3K9 | MAP3K9-DT | MAP4 | MAP4K1 | MAP4K1-AS1 | MAP4K2 | MAP4K3 | MAP4K3-DT | MAP4K4 | MAP4K5 | MAP6 | MAP6D1 | MAP7 | MAP7D1 | MAP7D2 | MAP7D3 | MAP9 | MAPK1 | MAPK10 | MAPK10-AS1 | MAPK11 | MAPK12 | MAPK13 | MAPK14 | MAPK15 | MAPK1IP1L | MAPK3 | MAPK4 | MAPK6 | MAPK6P2 | MAPK7 | MAPK8 | MAPK8IP1 | MAPK8IP1P2 | MAPK8IP2 | MAPK8IP3 | MAPK9 | MAPKAP1 | MAPKAPK2 | MAPKAPK3 | MAPKAPK5 | MAPKAPK5-AS1 | MAPKBP1 | MAPRE1 | MAPRE1P2 | MAPRE2 | MAPRE3 | MAPT | MAPT-AS1 | MAPT-IT1 | MARCHF1 | MARCHF10 | MARCHF11 | MARCHF11-DT | MARCHF2 | MARCHF3 | MARCHF4 | MARCHF5 | MARCHF6 | MARCHF6-DT | MARCHF7 | MARCHF8 | MARCHF9 | MARCKS | MARCKSL1 | MARCO | MARF1 | MARK1 | MARK2 | MARK2P5 | MARK2P9 | MARK3 | MARK4 | MARS1 | MARS2 | MARVELD1 | MARVELD2 | MARVELD3 | MAS1 | MAS1L